K Pharma,Inc. Logo

K Pharma,Inc.

4896 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区六本木七丁目7番7号
Sector:
Health Care
Industry:
Pharmaceuticals

Description

K Pharma, Inc. is a pioneering Japanese biotechnology company focused on transforming healthcare through innovative applications of iPS cell technology. Established as a spin-off from the Keio University School of Medicine, the company leverages groundbreaking research from esteemed professors in physiology and orthopedic surgery. K Pharma specializes in two main areas: iPS drug discovery, utilizing disease-specific iPS cells to develop targeted treatments, and regenerative medicine, aimed at creating therapies for spinal cord injuries and cerebral infarctions. With a mission to bring hope to patients worldwide, K Pharma is committed to advancing medical science and improving patient outcomes through its cutting-edge research and development initiatives.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-28 02:01
Inside Information Statement
臨時報告書
Japanese 24.2 KB
2025-03-28 02:00
Internal Control over Financial Reporting
内部統制報告書-第8期(2024/01/01-2024/12/31)
Japanese 22.4 KB
2025-03-28 02:00
Annual Report
有価証券報告書-第8期(2024/01/01-2024/12/31)
Japanese 1.5 MB
2025-03-28 02:00
Regulatory News Service
確認書
Japanese 8.8 KB
2024-08-14 08:00
Regulatory News Service
確認書
Japanese 8.9 KB
2024-08-14 08:00
Interim Report
半期報告書-第8期(2024/01/01-2024/12/31)
Japanese 182.0 KB
2024-05-14 02:00
Quarterly Report
四半期報告書-第8期第1四半期(2024/01/01-2024/03/31)
Japanese 136.5 KB
2024-05-14 02:00
Regulatory News Service
確認書
Japanese 8.8 KB
2024-03-29 02:30
Inside Information Statement
臨時報告書
Japanese 22.6 KB
2024-03-28 07:01
Regulatory News Service
確認書
Japanese 8.8 KB
2024-03-28 07:00
Internal Control over Financial Reporting
内部統制報告書-第7期(2023/01/01-2023/12/31)
Japanese 22.4 KB
2024-03-28 07:00
Annual Report
有価証券報告書-第7期(2023/01/01-2023/12/31)
Japanese 1.5 MB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nippon Shinyaku Co.,Ltd. Logo Nippon Shinyaku Co.,Ltd. Japan 4516
Noile-Immune Biotech Inc. Logo Noile-Immune Biotech Inc. Japan 4893
Novartis AG Logo Novartis AG Switzerland NOVN
Nur Ink Innovations Ltd. Logo Nur Ink Innovations Ltd. Israel NURI
Nxera Pharma Co., Ltd. Logo Nxera Pharma Co., Ltd. Japan 4565
ObsEva SA Logo ObsEva SA Switzerland OBSN
ODI Pharma AB Logo ODI Pharma AB Sweden ODI
Oncolys BioPharma Inc. Logo Oncolys BioPharma Inc. Japan 4588
OncoTherapy Science, Inc. Logo OncoTherapy Science, Inc. Japan 4564
OncoZenge AB Logo OncoZenge AB Sweden ONCOZ